Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-30,268
Closed -$13.7K 1760
2025
Q2
$13.7K Hold
30,268
﹤0.01% 1599
2025
Q1
$12.3K Buy
+30,268
New +$19.4K ﹤0.01% 1499
2023
Q4
Sell
-24,000
Closed -$18.1K 1297
2023
Q3
$18.1K Buy
+24,000
New +$18.3K ﹤0.01% 1150
2023
Q1
Sell
-10,000
Closed -$9.61K 1094
2022
Q4
$9.61K Sell
10,000
-1,000
-9% -$1.41K ﹤0.01% 889
2022
Q3
$24K Sell
11,000
-31,000
-74% -$107K ﹤0.01% 882
2022
Q2
$147K Hold
42,000
0.01% 828
2022
Q1
$212K Sell
42,000
-4,000
-9% -$20.3K 0.01% 874
2021
Q4
$288K Buy
46,000
+33,000
+254% +$225K 0.01% 778
2021
Q3
$103K Hold
13,000
0.01% 901
2021
Q2
$97K Hold
13,000
0.01% 861
2021
Q1
$79K Buy
+13,000
New +$100K 0.01% 782

Other funds holding VXRT

Kestra Private Wealth Services's VXRT Position: Q3 2025 in Review

Kestra Private Wealth Services sold out of Vaxart (VXRT) in Q3 2025, closing a stake of 30,268 shares — an estimated $13.7K sold.

Kestra Private Wealth Services first reported a position in VXRT in Q1 2021 and held it in 11 quarters. The position peaked at $288K in Q4 2021. 17 funds tracked by Wall St. Rank hold VXRT as of Q3 2025.

  • Kestra Private Wealth Services reported no remaining Vaxart position as of Q3 2025 after selling out during the quarter.
  • Kestra Private Wealth Services sold 30,268 Vaxart shares in Q3 2025, an estimated $13.7K.
  • Kestra Private Wealth Services first reported a position in Vaxart in Q1 2021 and held it in 11 quarters.
  • Kestra Private Wealth Services's Vaxart position peaked at $288K in Q4 2021.
  • 17 funds tracked by Wall St. Rank held Vaxart as of Q3 2025.

Based on Kestra Private Wealth Services's 13F filing for Q3 2025, filed 17 Nov 2025.